Trial Profile
Randomized, Double-Blind, Placebo-Controlled Three-Part Phase 1 Study of Safety, Tolerability, Pharmacokinetics, and Food Effect of MRX-4 Administered Orally to Healthy Volunteers in Single and Multiple Ascending Dose Cohorts to Evaluate Drug Interactions With Omeprazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2023
Price :
$35
*
At a glance
- Drugs Contezolid-acefosamil (Primary) ; Omeprazole
- Indications Diabetic foot; Gram-positive infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors MicuRx Pharmaceuticals
- 03 Sep 2017 Status changed from recruiting to completed.
- 03 Feb 2017 New trial record